查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370443

製藥連續製造市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

概要

市場概況：

2022年，全球製藥連續製造市場規模達到12億美元。展望未來，IMARC Group預計到2028年市場規模將達到23億美元，2023-2028年年複合成長率（CAGR）為11.6%。

藥品連續製造是指一種端到端的藥品生產方法，以最少的資本投資提高各種新藥和疫苗的品質和一致性。與批次相比，它以連續流程運行，更容易擴展，為製造商提供更好的控制和更高水平的自動化，並消除物理干涉。除此之外，藥品連續生產有助於最大限度地減少藥物配製時間、人為錯誤的風險、監控生產程序並提高產品品質以與監管指南一致。因此，該技術被製藥公司和合約製造組織 (CMO) 廣泛用於開發活性藥物成分 (API) 和藥物。目前有整合型、半連續型、控制型等。

製藥連續製造市場趨勢：

目前推動市場的主要因素之一是對以較低成本合成各種有效生物製劑的有效藥物生產系統的需求不斷成長。這可以進一步歸因於全球範圍內藥品短缺的加劇和多種慢性疾病的日益流行。此外，日益嚴重的健康問題，特別是在冠狀病毒病（COVID-19）大流行爆發期間，促使製藥公司使用連續生產技術來製造新型疫苗，這是另一個成長誘導因素。與此一致的是，重大技術進步，例如藥品製造方法的快速自動化和人工智慧（AI）解決方案的大規模整合，正在促進市場成長。其他因素，例如製藥業的顯著改善、持續的研發 (R&D) 活動以及人們對食品和藥物管理局 (FDA) 批准藥物的可用性的認知不斷提高，正在為市場創造積極的前景。

本報告回答的關鍵問題

  • 全球藥品連續製造市場有多大？
  • 2023-2028年全球藥品連續製造市場的預期成長率為何？
  • 推動全球藥品連續製造市場的關鍵因素是什麼？
  • COVID-19 對全球製藥連續製造市場有何影響？
  • 根據治療類型，全球藥品連續生產市場的細分如何？
  • 基於配方的全球藥品連續製造市場的細分是什麼？
  • 基於應用的全球製藥連續製造市場的細分是什麼？
  • 基於最終用戶的全球製藥連續製造市場的細分是什麼？
  • 全球藥品連續製造市場的重點區域有哪些？
  • 全球藥品連續製造市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球製藥連續製造市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按治療類型分類的市場區隔

  • 大分子
    • 市場走向
    • 市場預測
  • 小分子
    • 市場走向
    • 市場預測

第 7 章：按配方分類的市場區隔

  • 固體製劑
    • 市場走向
    • 市場預測
  • 液體和半固體製劑
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場區隔

  • 最終藥品製造
    • 市場走向
    • 市場預測
  • 原料藥製造
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 製藥公司
    • 市場走向
    • 市場預測
  • 合約製造組織
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baker Perkins
    • Coperion GmbH (Hillenbrand Inc.)
    • Eli Lilly and Company
    • GEA Group Aktiengesellschaft
    • Glatt GmbH
    • Korsch AG
    • Novartis AG
    • Siemens
    • SK biotek
    • Thermo Fisher Scientific Inc.
    • Viatris Inc.
Product Code: SR112023A5935

Abstract

Market Overview:

The global pharmaceutical continuous manufacturing market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.6% during 2023-2028.

Pharmaceutical continuous manufacturing refers to an end-to-end medication production approach that enhances the quality and consistency of various novel drugs and vaccines with minimal capital investments. As compared to batch processing, it operates in a continuous flow, is easier to scale, offers greater control to manufacturers and a higher level of automation, and eliminates physical intervention. Apart from this, pharmaceutical continuous manufacturing aids in minimizing the medicine formulation duration, risk of human errors, monitoring the production procedures, and improving the product quality to harmonize with the regulatory guidelines. Consequently, the technique is extensively utilized by pharmaceutical companies and contract manufacturing organizations (CMOs) to develop active pharmaceutical ingredients (API) and medicines. At present, it is available in integrated, semi-continuous, and control types.

Pharmaceutical Continuous Manufacturing Market Trends:

One of the primary factors currently driving the market is the increasing demand for effective medicine production systems for composing various effective biologics at a lower cost. This can be further attributed to the rising drug shortages and the growing prevalence of several chronic ailments across the globe. Additionally, the rising health concerns, especially during the coronavirus disease (COVID-19) pandemic outbreak, have prompted pharmaceutical companies to use continuous manufacturing techniques to compose novel vaccines, which is acting as another growth-inducing factor. In line with this, significant technological advancements, such as rapid automation in the pharmaceutical manufacturing methodology and the large-scale integration of artificial intelligence (AI) solutions, are contributing to the market growth. Other factors, such as significant improvements in the pharmaceutical sector, ongoing research and development (R&D) activities, and the escalating awareness about the availability of food and drug administration (FDA) approved medicines, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on therapeutics type, formulation, application and end user.

Breakup by Therapeutics Type:

Large Molecules

Small Molecules

Breakup by Formulation:

Solid Formulation

Liquid and Semi-solid Formulation

Breakup by Application:

Final Drug Product Manufacturing

API Manufacturing

Breakup by End User:

Pharmaceutical Companies

Contract Manufacturing Organizations

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens, SK biotek, Thermo Fisher Scientific Inc. and Viatris Inc.

Key Questions Answered in This Report

  • 1. How big is the global pharmaceutical continuous manufacturing market?
  • 2. What is the expected growth rate of the global pharmaceutical continuous manufacturing market during 2023-2028?
  • 3. What are the key factors driving the global pharmaceutical continuous manufacturing market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical continuous manufacturing market?
  • 5. What is the breakup of the global pharmaceutical continuous manufacturing market based on the therapeutics type?
  • 6. What is the breakup of the global pharmaceutical continuous manufacturing market based on formulation?
  • 7. What is the breakup of the global pharmaceutical continuous manufacturing market based on the application?
  • 8. What is the breakup of the global pharmaceutical continuous manufacturing market based on the end user?
  • 9. What are the key regions in the global pharmaceutical continuous manufacturing market?
  • 10. Who are the key players/companies in the global pharmaceutical continuous manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Continuous Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapeutics Type

  • 6.1 Large Molecules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Molecules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Formulation

  • 7.1 Solid Formulation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Liquid and Semi-solid Formulation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Final Drug Product Manufacturing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 API Manufacturing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Contract Manufacturing Organizations
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Baker Perkins
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Coperion GmbH (Hillenbrand Inc.)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Eli Lilly and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 GEA Group Aktiengesellschaft
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Glatt GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Korsch AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Siemens
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 SK biotek
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Viatris Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pharmaceutical Continuous Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Therapeutics Type (in %), 2022
  • Figure 5: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Formulation (in %), 2022
  • Figure 6: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pharmaceutical Continuous Manufacturing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pharmaceutical Continuous Manufacturing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: North America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: North America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: United States: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: United States: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Canada: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Canada: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: China: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: China: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Japan: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Japan: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: India: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: India: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: South Korea: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: South Korea: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Australia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Australia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Indonesia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Indonesia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Europe: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Europe: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Germany: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Germany: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: France: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: France: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: United Kingdom: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: United Kingdom: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Italy: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Italy: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Spain: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Spain: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Russia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Russia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Latin America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Latin America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Brazil: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Brazil: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Mexico: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Mexico: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Breakup by Country (in %), 2022
  • Figure 75: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Global: Pharmaceutical Continuous Manufacturing Industry: SWOT Analysis
  • Figure 77: Global: Pharmaceutical Continuous Manufacturing Industry: Value Chain Analysis
  • Figure 78: Global: Pharmaceutical Continuous Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Continuous Manufacturing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Therapeutics Type (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Formulation (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Pharmaceutical Continuous Manufacturing Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Continuous Manufacturing Market: Key Players